Company · CIK 0001398733 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Aquestive Therapeutics, Inc. · AQST
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 16, 2:00 pm EDT | Daniel BarberPresident and CEO, Director | 25,000 | $4.82 | $120,487 | 652,317 | −3.69% | 10b5-1 |
| Sep 9, 2026 SForm 4 → | Sep 11, 11:07 am EDT | Sherry KorczynskiChief Commercial Officer | 8,750 | $5.22 | $45,675 | 235,689 | −3.58% | 10b5-1 |
| Sep 9, 2026 MForm 4 → | Sep 11, 11:07 am EDT | Sherry KorczynskiChief Commercial Officer | 8,750 | $2.65 | $23,188 | 244,439 | — | 10b5-1 |
| Sep 9, 2026 XForm 4 → | Sep 10, 9:21 am EDT | Peter E. BoydChief People Officer | 2,293 | $0.96 | $2,201 | 284,024 | — | |
| Sep 8, 2026 XForm 4 → | Sep 9, 5:10 pm EDT | Daniel BarberPresident and CEO, Director | 91,743 | $0.96 | $88,073 | 677,317 | — | |
| Sep 3, 2026 XForm 4 → | Sep 8, 4:06 pm EDT | Cassie JungChief Operating Officer | 4,587 | $0.96 | $4,404 | 206,833 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 MForm 4 → | Sep 11, 11:07 am EDT | Sherry KorczynskiChief Commercial Officer | 8,750 | — | — | 26,250 | — | 10b5-1 |
| Sep 9, 2026 XForm 4 → | Sep 10, 9:21 am EDT | Peter E. BoydChief People Officer | 2,293 | — | — | 0 | — | |
| Sep 8, 2026 XForm 4 → | Sep 9, 5:10 pm EDT | Daniel BarberPresident and CEO, Director | 91,743 | — | — | 0 | — | |
| Sep 3, 2026 XForm 4 → | Sep 8, 4:06 pm EDT | Cassie JungChief Operating Officer | 4,587 | — | — | 0 | — |